{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T05:36:40Z","timestamp":1740202600310,"version":"3.37.3"},"reference-count":14,"publisher":"National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)","issue":"4","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. oncol."],"abstract":"<jats:p>Epithelioid hemangioendothelioma is a rare vascular sarcoma commonly occurring in the liver, soft tissues, and organs of the chest cavity. This study provides a detailed description of the clinical presentation, diagnosis, and treatment of epithelioid hemangioendothelioma of the ovary in a 71-year-old patient. According to the pathohistological examination, a mesenchymal tumor of the ovary with epithelioid cells was diagnosed. The immunohistochemical tests confirmed the diagnosis of epithelioid hemangioendothelioma. This clinical case is of interest for clinical practitioners due to the rare location of the tumor in female reproductive organs, which has not been previously documented in the medical literature.<\/jats:p>","DOI":"10.15407\/exp-oncology.2024.04.402","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:47:09Z","timestamp":1740156429000},"page":"402-407","source":"Crossref","is-referenced-by-count":0,"title":["Ovarian Epithelioid Hemangioendothelioma. Case Report"],"prefix":"10.15407","volume":"46","author":[{"given":"V.","family":"SVINTSITSKIY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"TSIP","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"NESPRYADKO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"SAMOKHVALOVA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"KHOPTIANA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"YERIUSHKIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"KROTEVYCH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"TROKHYMYCH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"SKORODA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"32237","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Can- cer. 1982;50(5):970-981. https:\/\/doi.org\/10.1002\/1097-0142(19820901)50:5<970::aid-cncr2820500527>3.0.co; 2-z","DOI":"10.1002\/1097-0142(19820901)50:5<970::AID-CNCR2820500527>3.0.CO;2-Z"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Wang ZB, Yuan J, Chen W, Wei LX. Transcription factor ERG is a specific and sensitive diagnostic marker for hepatic angiosarcoma. World J Gastroenterol. 2014;20(13):3672-3679. https:\/\/doi.org\/10.3748\/wjg.v20.i13.3672","DOI":"10.3748\/wjg.v20.i13.3672"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Lau K, Massad M, Pollak C, et al. Clinical patterns and outcome in epithelioid hemangioendothelioma with or with- out pulmonary involvement: insights from an internet registry in the study of a rare cancer. Chest. 2011;140(5):1312- 1318. https:\/\/doi.org\/10.1378\/chest.11-0039","DOI":"10.1378\/chest.11-0039"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Stacchiotti S, Frezza AM, Blay JY, et al. Ultra-rare sarcomas: a consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer. 2021;127(16):2934-2942. https:\/\/doi.org\/10.1002\/cncr.33618","DOI":"10.1002\/cncr.33618"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"de Pinieux G, Karanian M, Le Loarer F, et al. Nationwide incidence of sarcomas and connective tissue tumors of in- termediate malignancy over four years using an expert pathology review network. PLoS ONE. 2021;16(2):e0246958. https:\/\/doi.org\/10.1371\/journal.pone.0246958","DOI":"10.1371\/journal.pone.0246958"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, et al. WHO Classification of Tumours Editorial Board. The 2019 WHO clas- sification of tumours of the digestive system. Histopathology. 2020;76:182-188. https:\/\/doi.org\/10.1111\/his.13975","DOI":"10.1111\/his.13975"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Tomassen T, Versleijen-Jonkers YMH, Hillebrandt-Roeffen MHS, et al. Prognostic factors in epithelioid hemangio- endothelioma: Analysis of a nationwide molecularly\/immunohistochemically confirmed cohort of 57 cases. Cancers (Basel). 2023;15(13):3304. https:\/\/doi.org\/10.3390\/cancers15133304","DOI":"10.3390\/cancers15133304"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Stacchiotti S, Miah AB, Frezza AM, et al. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts. ESMO Open. 2021;6(3):100170. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100170.","DOI":"10.1016\/j.esmoop.2021.100170"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Radzikowska E, Szczepulska-W\u00f3jcik E, Chabowski M, et al. Pulmonary epithelioid haemangioendothelioma-Inter- feron 2-alpha treatment-case report. Adv Respir Med. 2008;76(4):281-285. https:\/\/doi.org\/10.5603\/ARM.27887","DOI":"10.5603\/ARM.27887"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Thomas RM, Aloia TA, Truty MJ, et al. Treatment sequencing strategy for hepatic epithelioid haemangioendothe- lioma. HPB (Oxford). 2014;16:677-685. https:\/\/doi.org\/ 10.1111\/hpb.12202","DOI":"10.1111\/hpb.12202"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Esma S, Marie-Christine SP, Jean G et al. Metastatic hepatic epithelioid hemangio-endothelioma: long-term response to sunitinib malate. Oncol Res Treat. 2014;37(3):124-126. https:\/\/doi.org\/10.1159\/000360208","DOI":"10.1159\/000360208"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Mayur V, Mohammed S, Radwan D, et al. Hepatic hemangioendothelioma: An update. World J Gastrointest Oncol. ;12(3):248-266. https:\/\/doi.org\/10.4251\/wjgo.v12.i3.248","DOI":"10.4251\/wjgo.v12.i3.248"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Agulnik M, Yarber JL, Okuno SH, et al. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol. 2013;24(1):257-263. https:\/\/doi.org\/10.1093\/ annonc\/mds237","DOI":"10.1093\/annonc\/mds237"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Shuang M, Ryan K, Ajaybabu V P, et al. The TAZ-CAMTA1 fusion protein promotes tumorigenesis via con- nective tissue growth factor and Ras-MAPK signaling in epithelioid hemangioendothelioma. Clin Cancer Res. 2022;28(14):3116-3126. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-0421","DOI":"10.1158\/1078-0432.CCR-22-0421"}],"container-title":["Experimental Oncology"],"original-title":[],"link":[{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/download\/439\/394","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/download\/439\/394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:41:17Z","timestamp":1740159677000},"score":1,"resource":{"primary":{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/view\/439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2,20]]}},"URL":"https:\/\/doi.org\/10.15407\/exp-oncology.2024.04.402","relation":{},"ISSN":["2312-8852","1812-9269"],"issn-type":[{"value":"2312-8852","type":"electronic"},{"value":"1812-9269","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,20]]}}}